We see meaningful improvement and remain confident in the company's wide moat.
The wide-moat company dominates medical technology.
With consistency that we rarely see in medical technology, Stryker has delivered another quarter of strong growth across all three of its segments.
Wide-moat Zoetis' purchase of Abaxis makes strategic sense but doesn't threaten narrow-moat Idexx Labs.
The wide-moat company leads the market in medical technology.
Few can match the company's pervasive presence in hospitals.
We think he’ll bring a much-needed new perspective to the company.